Dianthus Therapeutics, Inc. (DNTH:NASDAQ) closed at $74.76 on October 14, 2026, down 3.64% on the day. The stock trades 36.6% below its 52-week high of $117.88 and 132.0% above its 52-week low of $32.22. Over the past year, it gained 106.5%. Dianthus Therapeutics, Inc. is part of the Health Care sector.
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -8.35% | -28.64% | -29.20% | -18.67% | +106.52% |
In 252 trading sessions since October 14, 2025, DNTH closed higher on 127 days (50%). Its best day was March 9, 2026 (+21.52%) and its worst was June 10, 2026 (-9.64%). The stock moved 10% or more in a single session 5 times. It opened at least 5% above the previous day's high 1 time.
Magenta Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing novel medicines to extend the curative power of stem cell transplant, gene therapy, genome editing, and cell therapy. The pipeline of the company includes MGTA-117, MGTA-145, and others.
Find more stocks like DNTH with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.